RPS6KB1 and breast cancer: After the inhibitor treatments with Ly294002 and rapamycin, significantly lower or no protein expression of Thr389-phosphorylated p70S6K was detected by Western blotting in all the rapamycin- and Ly294002-treated breast cancer cell lines as compared to non-treated samples (Figure 3A–B).